Concomitant chronic lymphocytic leukemia and acute myeloid leukemia: Evidence of simultaneous expansion of two independent clones

The simultaneous appearance of chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML) has been rarely reported, with AML occurring more frequently as a secondary event in patients receiving cytotoxic drugs for a primary lymphoproliferative disorder. We describe a case of simultaneous CLL and AML documented by morphological and cytometric analysis in a previously untreated patient. In particular, on the basis of morphological and immunological features, the patient was diagnosed as being affected by CD34 + /CD13 + /CD33 + /HLA-DR + /CD7 + FAB-M2 AML, along with a B-CLL characterized by neoplastic cells expressing a VH3-53/D3-22/JH4 Ig, bearing, on average, 3.9% IgVH mutations without evidence of antigen-driven selection. To establish whether the two neoplastic cell populations shared some common molecular signature, we performed IgH gene rearrangement studies on CD34 + /CD19− and CD34−/CD19 + immunomagnetically sorted cell populations: only genomic DNA from the CD19 + /CD34− cell fraction revealed the presence of the IgH gene rearrangement. These results provide evidence that the rare concomitant association of CLL and AML likely arises from simultaneous expansion of two independent clones.

[1]  R. Hromas,et al.  Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4. , 2005, Blood.

[2]  C. Pucillo,et al.  Analysis of IgVH gene mutations in B cell chronic lymphocytic leukaemia according to antigen‐driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery , 2004, British journal of haematology.

[3]  D. Ben‐Yehuda,et al.  Therapy-related Leukemia and Myelodysplasia: Evolving Concepts of Pathogenesis and Treatment , 2004, Hematology.

[4]  Axel Benner,et al.  Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. , 2002, Blood.

[5]  T. Graf.  Differentiation plasticity of hematopoietic cells. , 2002, Blood.

[6]  M. Greene,et al.  Solid tumors after chronic lymphocytic leukemia. , 2001, Blood.

[7]  F. Mandelli,et al.  Molecular Remission Following High-Dose Hydroxyurea and Fludarabine Plus Cytarabine in a Patient with Simultaneous Acute Myeloid Leukemia and Low-Grade Lymphoma , 2001, Leukemia & lymphoma.

[8]  E. Ranheim,et al.  Sensitive Detection of Clonal Immunoglobulin Rearrangements in Frozen and Paraffin Embedded Tissues by Polymerase Chain Reaction Heteroduplex Analysis , 2000, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[9]  A. Pinto,et al.  Normalizing complementary DNA by quantitative reverse transcriptase-polymerase chain reaction of beta2-microglobulin: molecular monitoring of minimal residual disease in acute promyelocytic leukemia. , 2000, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[10]  E. Macintyre,et al.  Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease , 1999, Leukemia.

[11]  N. Chiorazzi,et al.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.

[12]  D. Arber,et al.  Untreated chronic lymphocytic leukemia concurrent with or followed by acute myelogenous leukemia or myelodysplastic syndrome. A report of five cases and review of the literature. , 1999, American journal of clinical pathology.

[13]  L. Rassenti,et al.  Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. , 1998, The Journal of clinical investigation.

[14]  F. Davi,et al.  Early onset of immunoglobulin heavy chain gene rearrangements in normal human bone marrow CD34+ cells. , 1997, Blood.

[15]  T. Matsuda,et al.  Prognostic significance of immunoglobulin heavy chain gene rearrangement in patients with acute myelogenous leukemia , 1997, Leukemia.

[16]  G. Mitterbauer,et al.  148 Myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) supervening previously untreated chronic B-lymphocytic leukemia (B-cll): Demonstration of the concomitant presence of two different malignant clones by immunologic and molecular analysis , 1997 .

[17]  U. Jaeger,et al.  Myelodysplastic syndrome/acute myeloid leukemia supervening previously untreated chronic B-lymphocytic leukemia: demonstration of the concomitant presence of two different malignant clones by immunologic and molecular analysis , 1997, Annals of Hematology.

[18]  D. Serraino,et al.  CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. , 1997, Blood.

[19]  S. Rives,et al.  Simultaneous occurrence of B-cell chronic lymphocytic leukemia and chronic myeloid leukemia with further evolution to lymphoid blast crisis. , 1997, Haematologica.

[20]  Farhi Dc,et al.  Reactive plasmacytosis and lymphocytosis in acute myeloid leukemia. , 1994 .

[21]  N. Rosenthal,et al.  Reactive plasmacytosis and lymphocytosis in acute myeloid leukemia. , 1994, Hematologic pathology.

[22]  E. Estey,et al.  Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia. , 1994, Leukemia.

[23]  B. Hankey,et al.  Second cancers in patients with chronic lymphocytic leukemia. , 1992, Journal of the National Cancer Institute.

[24]  R. Hoover,et al.  Subsequent cancer in patients with chronic lymphocytic leukemia--a possible immunologic mechanism. , 1978, Journal of the National Cancer Institute.